Abstract
Persistent growth forms of Chlamydia pneumoniae have been associated with chronic infections in vivo. We investigated the effects of first-line therapeutics on the induction of persistence by monitoring recoverable organisms, gene expression of membrane proteins, and morphology. We found that all of the antibiotics tested have distinct and subinhibitory concentrations at which they induce persistence.
Original language | English |
---|---|
Journal | Antimicrobial Agents and Chemotherapy |
Volume | 48 |
Issue number | 4 |
Pages (from-to) | 1402-1405 |
Number of pages | 4 |
ISSN | 0066-4804 |
DOIs | |
Publication status | Published - 01.04.2004 |
Research Areas and Centers
- Academic Focus: Center for Infection and Inflammation Research (ZIEL)